<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">

  <!-- PACE Progress Bar START -->
  
    
<script src="https://raw.githubusercontent.com/HubSpot/pace/v1.0.2/pace.min.js"></script>

    
<link rel="stylesheet" href="https://github.com/HubSpot/pace/raw/master/themes/orange/pace-theme-flash.css">

  
  

  <!-- PACE Progress Bar START -->

  
  <title>Hexo</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  
  
  
  <meta name="description" content="文章来源： 《经济学人》Jun 5th 2021 期 Business 栏目 The big-pharma firm that saw the future能够看到未来的大型制药公司 Schumpeter熊彼特 ![image-20210611095408536](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&amp;#x">
<meta property="og:type" content="article">
<meta property="og:title" content="Hexo">
<meta property="og:url" content="http://example.com/2021/06/11/Day416-The%20Economist/index.html">
<meta property="og:site_name" content="Hexo">
<meta property="og:description" content="文章来源： 《经济学人》Jun 5th 2021 期 Business 栏目 The big-pharma firm that saw the future能够看到未来的大型制药公司 Schumpeter熊彼特 ![image-20210611095408536](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&amp;#x">
<meta property="og:locale" content="en_US">
<meta property="article:published_time" content="2021-06-11T01:52:13.422Z">
<meta property="article:modified_time" content="2021-06-11T01:54:25.799Z">
<meta property="article:author" content="John Doe">
<meta name="twitter:card" content="summary">
  
    <link rel="alternate" href="/atom.xml" title="Hexo" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="https://cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="https://code.jquery.com/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/bootstrap/3.0.2/css/bootstrap.min.css" >
  <link rel="stylesheet" href="/css/hiero.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >
  
    <link rel="stylesheet" href="/css/vdonate.css" >
  

  <!-- Custom CSS -->
  
<link rel="stylesheet" href="/css/my.css">

  <!-- Google Adsense -->
  
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
      (adsbygoogle = window.adsbygoogle || []).push({
          google_ad_client: "ca-pub-0123456789ABCDEF",
          enable_page_level_ads: true
      });
  </script>
  
<meta name="generator" content="Hexo 6.3.0"></head>

<script>
var themeMenus = {};

  themeMenus["/"] = "Home"; 

  themeMenus["/archives"] = "Archives"; 

  themeMenus["/categories"] = "Categories"; 

  themeMenus["/tags"] = "Tags"; 

  themeMenus["/about"] = "About"; 

</script>


  <body data-spy="scroll" data-target="#toc" data-offset="50">


  <header id="allheader" class="site-header" role="banner">
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="Hexo" rel="home"> Hexo </a>
            
          </h1>

          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>
            <div class="clearfix sf-menu">

              <ul id="main-nav" class="nmenu sf-js-enabled">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>


      </div>
  </div>
</header>


  <div id="originBgDiv" style="background: #fff; width: 100%;">

      <div style="max-height:600px; overflow: hidden;  display: flex; display: -webkit-flex; align-items: center;">
        <img id="originBg" width="100%" alt="" src="">
      </div>

  </div>

  <script>
  function setAboutIMG(){
      var imgUrls = "css/images/pose.jpg,https://source.unsplash.com/collection/954550/1920x1080".split(",");
      var random = Math.floor((Math.random() * imgUrls.length ));
      if (imgUrls[random].startsWith('http') || imgUrls[random].indexOf('://') >= 0) {
        document.getElementById("originBg").src=imgUrls[random];
      } else {
        document.getElementById("originBg").src='/' + imgUrls[random];
      }
  }
  bgDiv=document.getElementById("originBgDiv");
  if(location.pathname.match('about')){
    setAboutIMG();
    bgDiv.style.display='block';
  }else{
    bgDiv.style.display='none';
  }
  </script>



  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-Day416-The Economist" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
    <div class="article-meta">
      
	Posted on <a href="/2021/06/11/Day416-The%20Economist/" class="article-date">
	  <time datetime="2021-06-11T01:52:13.422Z" itemprop="datePublished">June 11, 2021</time>
	</a>

      
	<span id="busuanzi_container_page_pv">
	  本文总阅读量<span id="busuanzi_value_page_pv"></span>次
	</span>

    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <p>文章来源： 《经济学人》Jun 5th 2021 期 Business 栏目</p>
<h1 id="The-big-pharma-firm-that-saw-the-future"><a href="#The-big-pharma-firm-that-saw-the-future" class="headerlink" title="The big-pharma firm that saw the future"></a>The big-pharma firm that saw the future</h1><p>能够看到未来的大型制药公司</p>
<h6 id="Schumpeter"><a href="#Schumpeter" class="headerlink" title="Schumpeter"></a>Schumpeter</h6><p>熊彼特</p>
<p>![image-20210611095408536](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-user-images&#x2F;image-20210611095408536.png)</p>
<h5 id="Long-ago-Roche-bet-on-personalised-health-care-Now-its-time-has-come"><a href="#Long-ago-Roche-bet-on-personalised-health-care-Now-its-time-has-come" class="headerlink" title="Long ago Roche bet on personalised health care. Now its time has come"></a>Long ago Roche bet on personalised health care. Now its time has come</h5><p>很久以前，罗氏押注于个性化医疗保健。它的机会来了</p>
<blockquote>
<p>Jun 5th 2021 </p>
</blockquote>
<p>ROCHE IS A strange entity. The Swiss giant is the world’s second-biggest drugmaker and one of big pharma’s most profitable firms. But its largest shareholding group, mostly <strong>descended from</strong> Fritz Hoffmann-La Roche, who founded the company in 1896, is led by André Hoffmann, a nature lover and sustainability advocate who believes that the purpose of business is not mainly to make money. Even its bosses <strong>are discouraged from</strong> making a quick franc. Severin Schwan, an Austrian who has led the company since 2008, is only Roche’s seventh CEO in 125 years. Much of his pay is tied up in company stock for ten years, giving him, as he puts it, “literally a vested interest” in its long-term future.</p>
<blockquote>
<p>discourage 阻止</p>
<p>discourage sb from doing sth 阻止某人干某事</p>
<p>literally 确确实实地；简直</p>
</blockquote>
<p>罗氏是一个奇怪的实体。这家瑞士巨头是世界第二大制药商，也是大型制药公司中最赚钱的公司之一。但该公司最大的持股集团大多是创立公司的Fritz Hoffmann-La Roche的后裔，该公司由André Hoffmann领导，他是一位自然爱好者和可持续发展倡导者，他认为做生意的主要目的不在于赚钱。甚至连它的老板们也不愿赚快钱。自2008年以来一直领导公司的奥地利人Severin Schwan是罗氏125年来第七位首席执行官。十年来，他的大部分薪酬都与公司股票挂钩，用他自己的话说，这让他在公司的长期未来中获得了“实实在在的既得利益”。</p>
<p><strong>Another thing sets Roche apart from the crowd.</strong> For two decades it has nurtured an unflashy diagnostics division alongside its mainstay of drug production, <strong>in an effort to</strong> create more personalised health care. This unit, which accounts for almost a quarter of sales, has generated lower margins than pharmaceuticals, and <strong>puts off the sort of investors who yearn only for blockbuster medicines</strong>. Had it not been for the Hoffmanns’ patience, some suspect, activists would have forced Roche to sell it or spin it off long ago.</p>
<blockquote>
<p>mainstay 主要部分; 支柱 </p>
</blockquote>
<p>另一件事让罗氏与众不同。二十年来，该公司除了拥有支柱“药品生产”，还培育了一个不起眼的诊断部门，以创造更个性化的医疗保健。这个部门的销售额几乎占到总销售额的四分之一，其利润率低于制药业，也让那些只渴望畅销药品的投资者望而却步。一些人怀疑，如果不是Hoffmann的耐心，激进分子早就会迫使罗氏出售或分拆该公司。</p>
<p>And yet in the past year or so the ability to diagnose a disease in its early stages has <strong>fully come into its own</strong>. The division has helped the company through the covid-19 pandemic. Roche was not one of the star vaccine producers, but its workaday PCR and antigen tests <strong>bolstered profits</strong> despite <strong>a slowdown in</strong> cancer treatments, its biggest business. Moreover, advances in gene sequencing and other techniques from molecular biology helped identify SARS-CoV-2, the covid-19 virus, as well as <strong>ways to fight it</strong>. <strong>That has highlighted the value of combining biotechnology and diagnostics. These are both fields in which Roche excels</strong>.</p>
<blockquote>
<p>workaday 日常的</p>
<p>a slowdown in… …的减少</p>
</blockquote>
<p>然而，在过去一年左右的时间里，在疾病的早期阶段进行诊断的能力已经完全显现出来。该部门帮助公司度过了covid-19大流行病。罗氏不是明星疫苗生产商之一，但其日常的PCR和抗原检测提高了利润，尽管其最大的业务“癌症治疗”放缓。此外，基因测序和来自分子生物学的其他技术的进步帮助识别了新型冠状病毒SARS-CoV-2，以及抗击它的方法。这凸显了生物技术和诊断学结合的价值。这两个领域都是罗氏的强项。</p>
<p>Far from shedding diagnostics, Roche is now <strong>doubling down on it</strong>, <strong>expanding into</strong> digitisation and advanced data analytics to create individually tailored cancer treatments. This is, says Tim Haines, boss of Abingworth, a biotech venture-capital firm, “the golden age of diagnostics”. Bets placed years ago are <strong>making the stodgy-sounding</strong>, <strong>Basel-based company</strong> look prescient.</p>
<blockquote>
<p>prescient 有先见之明的</p>
</blockquote>
<p>罗氏非但没有放弃诊断，反而加倍投入，将业务扩展到数字化和先进的数据分析领域，以创建个性化的癌症治疗方案。生物技术风投公司Abingworth的老板Tim Haines说，现在是“诊断技术的黄金时代”。多年前的押注，让这家听起来古板、总部位于巴塞尔的公司看起来有先见之明。</p>
<p>Mr Schwan, whose background is in diagnostics, can <strong>barely contain his excitement</strong>. After a long conversation with The Economist, he came back for more a day later. As he explains, cancer is <strong>a panoply of</strong> diseases based on individual mutations. Diagnostics identifies genetic and other differences between patients, leading to the creation of more personalised treatments. The tailor-made market, by definition, is smaller than the one for blockbuster drugs, but if patients respond better to treatment, the value of drugs can be proportionally higher. Sifting through oceans of genomic data can produce yet more precision.</p>
<blockquote>
<p>a panoply of 一连串</p>
<p>tailor-made 非常适合的；定做的</p>
<p>proportionally 相应地</p>
</blockquote>
<p>Schwan先生的背景是诊断学，他几乎无法抑制自己的兴奋。在与《经济学人》进行了长时间的交谈后，他在一天后又回来了。正如他解释的那样，癌症是一种基于个体突变的一系列疾病。通过诊断可以识别患者之间的基因和其他差异，从而创造出更个性化的治疗方法。从定义上来看，量身定制的市场比畅销药物的市场要小，但如果患者对治疗有更好的反应，药物的价值就会成比例上升。对海量的基因组数据进行筛选可以产生更精确的结果。</p>
<p><strong>Accumulating reams of information on patients has long sat awkwardly with concerns about medical privacy.</strong> Less so now, Mr Schwan believes. He says the pandemic has helped <strong>change the mood in two ways</strong>. <strong>First</strong>, the use of data-crunching to speed up the fight against covid-19 has made health authorities, hospitals and doctors <strong>more amenable to</strong> the idea of sharing medical records—provided the information is anonymised. This is, after all, biotech, not big tech. “We are not in the advertising business,” he says. <strong>Second,</strong> regulators have shown what he describes as an “incredible” willingness to speed up drug approval by gaining access to clinical-trial data in real time. “Why should we not do the same for life-saving cancer medicines?”</p>
<blockquote>
<p>amenable 经得起检验的；顺从的；有服从义务的</p>
<p>amenable to proof&#x2F;demonstration «case, theory» 经得起验证&#x2F;论证的</p>
</blockquote>
<p>长期以来，积累患者的大量信息与医疗隐私问题一直存在尴尬地关系。Schwan 先生认为，现在不那么重要了。他说，疫情从两个方面改变了人们的情绪。首先，利用数据处理技术加快抗击covid-19的速度，使得卫生当局、医院和医生更愿意共享医疗记录，前提是信息是匿名的。毕竟，这是生物技术，不是大型科技。他说:“我们不是广告业。”其次，监管机构表现出了他所说的“令人难以置信”的意愿，即通过实时获取临床试验数据来加快药物审批。“为什么我们不应该对拯救生命的癌症药物采取同样的措施呢?”</p>
<p><strong>Roche</strong>, which has recently fallen behind Merck, an oncology rival, in immunotherapy treatments, <strong>has been eagerly waiting for this digital tide to turn. Two American acquisitions</strong> in 2018 could prove particularly fruitful. <strong>One is Foundation Medicine</strong>, a gene-sequencing company that can identify cancers from DNA in blood samples, instead of from tumour biopsies. <strong>The other is Flatiron Health</strong>, a specialist in cancer-related health records that generates data on patients from the real world, supplementing clinical trials. <strong>Both produce what Roche calls insights on cancer.</strong> Like its diagnostics business, not only do they help it further its own drug development; they also sell services to rivals, making them businesses in their own right. They are not yet profitable, but one day, Mr Schwan says, the “insights” business could be a third pillar for Roche—as big, if not bigger, than diagnostics and pharma.</p>
<blockquote>
<p>oncology 肿瘤学</p>
<p>immunotherapy 免疫治疗</p>
<p>biopsy 活组织检查</p>
</blockquote>
<p>罗氏最近在免疫治疗方面落后于肿瘤学竞争对手默克，它一直在急切地等待这股数字化浪潮的转变。2018年在对美国公司的两次收购可能会证明是特别成功的。一个是Foundation Medicine，这是一家基因测序公司，可以通过血液样本中的DNA而不是肿瘤活检来识别癌症。另一家是Flatiron Health，一家癌症相关健康记录方面的专家，从现实世界中生成患者的数据，补充临床试验。这两个收购案都表现出罗氏所谓的对癌症的洞察力。就像它的诊断业务一样，这些业务不仅帮助它进一步发展自己的药物开发;他们还向竞争对手出售服务，使其成为自己的业务。他们还没有盈利，但是Schwan先生说，总有一天，“洞察”业务可能会成为罗氏的第三大支柱，其规模甚至可能会比诊断和制药更大，如果不是这样，也会是一般大。</p>
<p><strong>There are potential pitfalls.</strong> Biology is <strong>as messy and unpredictable as nature itself.</strong> Data analytics may not be as useful in biotech as in other industries. Roche will not have the field to itself. Silicon Valley tech giants are already <strong>muscling in</strong>. And Europe, where Roche is based, has long been squeamish about <strong>data-gathering and privacy</strong>. If that continues to apply to medicine, it will hobble the region’s health-care industry.</p>
<blockquote>
<p>muscle in on sb’s territory 侵占某人的地盘</p>
<p>be squeamish about sth 对某事物神经质</p>
</blockquote>
<p>这里有潜在的陷阱。生物学就像自然界一样混乱和不可预测。数据分析在生物技术领域可能不如在其他行业有用。罗氏不会独占这个领域。硅谷的科技巨头已经在挤入市场。而罗氏公司总部所在的欧洲，长期以来一直对数据收集和隐私问题持谨慎态度。如果这种情况继续适用于医药行业，将会阻碍该地区的医疗保健行业。</p>
<p>That said, Roche has a record of pulling off the unexpected. Stefan Schneider of Vontobel, a Swiss investment firm, notes that it has accomplished <strong>the rare feat of</strong> keeping profit<strong>s ticking over</strong> even as patents on its three biggest cancer drugs, which had peak annual revenues of $21bn, have expired. Its immunotherapy drug, Tecentriq, has recently <strong>shown promising results</strong> in early-stage lung-cancer care, which may be a big breakthrough. And it has mastered the art of buying trendy biotech firms without spoiling their innovative fizz.</p>
<blockquote>
<p>tick over 空转；缓慢进行</p>
</blockquote>
<p>尽管如此，罗氏公司还是有完成意想不到的事件的成就。瑞士投资公司Vontobel的Stefan Schneider指出，尽管其三大抗癌药物的专利(最高年收入210亿美元)已经过期，但该公司依然保持了盈利，这是一项罕见的壮举。该公司的免疫治疗药物Tecentriq最近在早期肺癌治疗方面显示出了良好的效果，这可能是一项重大突破。它还掌握了收购流行生物技术公司而又不破坏其创新活力的技巧。</p>
<p>Black Schwan</p>
<p>Indeed, its success vindicates long-term thinking and shows that shareholders’ focus on notions like sustainability can co-exist with commercial success. For all the Hoffmann family’s influence, Mr Schwan is no softy. He <strong>defends high drug prices</strong> in America. He <strong>believes in</strong> strong intellectual-property protection. When America’s government this year <strong>threw</strong> its support <strong>behind</strong> patent waivers for covid-19 vaccines, he compared it to communist East Germany’s nationalisation of drugmakers. Roche may be unusual. As one of Europe’s few world-class megafirms, it is ballsy, too. ■</p>
<blockquote>
<p>vindicate 证明..有理</p>
<p>ballsy 有胆量的</p>
</blockquote>
<p>确实，它的成功证明了长远的思考是正确的，并表明股东对可持续性等概念的关注可以与商业成功共存。尽管有 Hoffmann家族的影响力，但Schwan并不软弱。他为美国高昂的药品价格辩护。他相信强有力的知识产权保护。当美国政府今年支持新冠肺炎疫苗的专利豁免时，他将其比作共产主义东德对制药企业的国有化。罗氏也许与众不同。作为欧洲为数不多的世界级巨头公司之一，它也很有胆量。■</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
      
        <div id="donation_div"></div>


<script src="/js/vdonate.js"></script>

<script>
var a = new Donate({
  title: '如果觉得我的文章对您有用，请随意打赏。您的支持将鼓励我继续创作!', // 可选参数，打赏标题
  btnText: 'Donate', // 可选参数，打赏按钮文字
  el: document.getElementById('donation_div'),
  wechatImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/WeChanQR.png',
  alipayImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/AliPayQR.jpg'
});
</script>
      
            
      
        
	<div id="comment">
		<!-- 来必力City版安装代码 -->
		<div id="lv-container" data-id="city" data-uid="MTAyMC8yOTQ4MS82MDQ5">
		<script type="text/javascript">
		   (function(d, s) {
		       var j, e = d.getElementsByTagName(s)[0];

		       if (typeof LivereTower === 'function') { return; }

		       j = d.createElement(s);
		       j.src = 'https://cdn-city.livere.com/js/embed.dist.js';
		       j.async = true;

		       e.parentNode.insertBefore(j, e);
		   })(document, 'script');
		</script>
		<noscript>为正常使用来必力评论功能请激活JavaScript</noscript>
		</div>
		<!-- City版安装代码已完成 -->
	</div>


      
    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2021/06/11/Day417-The%20Economist/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          (no title)
        
      </div>
    </a>
  
  
    <a href="/2021/06/10/Day415-The%20Economist/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title"></div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  <aside id="sidebar">
    <div id="toc" class="toc-article" style="overflow-y: scroll; max-width: 28%;">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-1"><a class="nav-link" href="#The-big-pharma-firm-that-saw-the-future"><span class="nav-number">1.</span> <span class="nav-text">The big-pharma firm that saw the future</span></a><ol class="nav-child"><li class="nav-item nav-level-6"><a class="nav-link" href="#Schumpeter"><span class="nav-number">1.0.0.0.0.1.</span> <span class="nav-text">Schumpeter</span></a></li></ol></li><li class="nav-item nav-level-5"><a class="nav-link" href="#Long-ago-Roche-bet-on-personalised-health-care-Now-its-time-has-come"><span class="nav-number">1.0.0.0.1.</span> <span class="nav-text">Long ago Roche bet on personalised health care. Now its time has come</span></a></li></ol></li></ol></li></ol></li></ol></li></ol>
    
    </div>
  </aside>
</section>
        
      </div>
      <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2023 Hexo All Rights Reserved.
          
            <span id="busuanzi_container_site_uv">
              本站访客数<span id="busuanzi_value_site_uv"></span>人次  
              本站总访问量<span id="busuanzi_value_site_pv"></span>次
            </span>
          
      </div>
      <div class="site-credit">
        Theme by <a href="https://github.com/iTimeTraveler/hexo-theme-hiero" target="_blank">hiero</a>
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var contentdiv = document.getElementById("content");

    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
</script>

<!-- Custome JS -->

<script src="/js/my.js"></script>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css">

  
<script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>




<script src="/js/scripts.js"></script>


<script src="https://stackpath.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>


<script src="/js/main.js"></script>








  <div style="display: none;">
    <script src="https://s95.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
  </div>



	<script async src="https://dnqof95d40fo6.cloudfront.net/atw7f8.js">
	</script>






  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
